Kim R. Kampen
- Molecular Biology top 10%
- Cancer Research top 10%
- Oncology
- Hematology top 5%
- Immunology
- Co-authors
- Kim De KeersmaeckerSergey O. SulimaStijn VereeckeEveline S.J.M. de BontArja ter ElstJelle VerbeeckLaura FancelloFrank J.G. Scherpen
- Topics
- Acute Myeloid Leukemia Research (14 papers)RNA modifications and cancer (10 papers)Angiogenesis and VEGF in Cancer (8 papers)
- Partner nations
- NetherlandsBelgiumUnited States
In The Last Decade
Kim R. Kampen
46 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 103
- Molecular Biology 910
- Cancer Research 285
- Oncology 215
- Hematology 194
- Immunology 119
Countries citing papers authored by Kim R. Kampen
This map shows the geographic impact of Kim R. Kampen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim R. Kampen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim R. Kampen more than expected).
Fields of papers citing papers by Kim R. Kampen
This network shows the impact of papers produced by Kim R. Kampen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim R. Kampen. The network helps show where Kim R. Kampen may publish in the future.
Co-authorship network of co-authors of Kim R. Kampen
This figure shows the co-authorship network connecting the top 25 collaborators of Kim R. Kampen. A scholar is included among the top collaborators of Kim R. Kampen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim R. Kampen. Kim R. Kampen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 11 | |
| 5 | 14 | |
| 6 | 29 | |
| 7 | 57 | |
| 8 | 11 | |
| 9 | 26 | |
| 10 | 47 | |
| 11 | 14 | |
| 12 | 19 | |
| 13 | 2 | |
| 14 | 47 | |
| 15 | 23 | |
| 16 | 5 | |
| 17 | 17 | |
| 18 | 49 | |
| 19 | 8 | |
| 20 | 20 |
About Kim R. Kampen
Kim R. Kampen is a scholar working on Hematology, Cancer Research and Molecular Biology, having authored 47 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), RNA modifications and cancer (10 papers) and Angiogenesis and VEGF in Cancer (8 papers). The work is most often cited by research in Cancer Research (285 citations), Hematology (194 citations) and Molecular Biology (910 citations). Kim R. Kampen has collaborated with scholars based in Netherlands, Belgium and United States. Frequent co-authors include Kim De Keersmaecker, Sergey O. Sulima, Stijn Vereecke, Eveline S.J.M. de Bont, Arja ter Elst, Jelle Verbeeck, Laura Fancello, Frank J.G. Scherpen, Marc Vooijs and Jan Cools. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.